Mackenzie Financial Corp Purchases Shares of 18,626 Health Catalyst, Inc. (NASDAQ:HCAT)

Mackenzie Financial Corp acquired a new position in Health Catalyst, Inc. (NASDAQ:HCAT) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 18,626 shares of the company’s stock, valued at approximately $172,000.

Several other institutional investors have also recently modified their holdings of the company. Swiss National Bank raised its stake in shares of Health Catalyst by 1.7% during the third quarter. Swiss National Bank now owns 123,600 shares of the company’s stock worth $1,251,000 after acquiring an additional 2,100 shares in the last quarter. New York State Common Retirement Fund boosted its position in Health Catalyst by 3.9% during the third quarter. New York State Common Retirement Fund now owns 121,385 shares of the company’s stock valued at $1,228,000 after buying an additional 4,599 shares during the period. Principal Financial Group Inc. grew its stake in shares of Health Catalyst by 38.4% during the third quarter. Principal Financial Group Inc. now owns 25,793 shares of the company’s stock valued at $261,000 after buying an additional 7,152 shares during the last quarter. Perigon Wealth Management LLC increased its holdings in shares of Health Catalyst by 34.1% in the fourth quarter. Perigon Wealth Management LLC now owns 40,697 shares of the company’s stock worth $377,000 after buying an additional 10,355 shares during the period. Finally, Stratos Wealth Partners LTD. purchased a new position in shares of Health Catalyst in the third quarter worth about $114,000. 85.00% of the stock is currently owned by institutional investors.

Health Catalyst Stock Performance

Shares of HCAT stock opened at $6.34 on Tuesday. The firm has a market capitalization of $371.29 million, a PE ratio of -3.02 and a beta of 1.29. The company has a 50 day moving average price of $7.32 and a 200-day moving average price of $8.23. Health Catalyst, Inc. has a 52 week low of $5.45 and a 52 week high of $14.37. The company has a quick ratio of 4.42, a current ratio of 4.42 and a debt-to-equity ratio of 0.62.

Health Catalyst (NASDAQ:HCAT) last issued its quarterly earnings data on Thursday, February 22nd. The company reported ($0.21) EPS for the quarter, topping the consensus estimate of ($0.27) by $0.06. The company had revenue of $75.08 million during the quarter, compared to analyst estimates of $73.67 million. Health Catalyst had a negative return on equity of 12.19% and a negative net margin of 39.92%. As a group, equities research analysts expect that Health Catalyst, Inc. will post -0.47 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on HCAT. Piper Sandler restated an “overweight” rating and set a $15.00 price target (down from $17.00) on shares of Health Catalyst in a research report on Friday, February 23rd. Guggenheim upgraded shares of Health Catalyst from a “neutral” rating to a “buy” rating and set a $14.00 price target on the stock in a report on Friday, January 26th. Cantor Fitzgerald reiterated an “overweight” rating and set a $16.00 target price on shares of Health Catalyst in a report on Wednesday, April 10th. Evercore ISI reduced their target price on shares of Health Catalyst from $11.00 to $10.00 and set an “outperform” rating on the stock in a research report on Friday, February 23rd. Finally, KeyCorp reiterated a “sector weight” rating on shares of Health Catalyst in a research note on Wednesday, April 10th. Four equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $12.10.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.